The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice
Kannisto, K, Rehnmark, S, Slätis, K, Webb, P, Larsson, L, Gåfvels, M, Eggertsen, G, Parini, P
Published in Atherosclerosis (01.12.2014)
Published in Atherosclerosis (01.12.2014)
Get full text
Journal Article
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease
Carrero, J. J., Qureshi, A. R., Axelsson, J., Yilmaz, M. I., Rehnmark, S., Witt, M. R., Bárány, P., Heimbürger, O., Suliman, M. E., Alvestrand, A., Lindholm, B., Stenvinkel, P.
Published in Journal of internal medicine (01.12.2007)
Published in Journal of internal medicine (01.12.2007)
Get full text
Journal Article
Signal transduction in brown adipose tissue recruitment: noradrenaline and beyond
Cannon, B, Jacobsson, A, Rehnmark, S, Nedergaard, J
Published in International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity (01.03.1996)
Get more information
Published in International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity (01.03.1996)
Journal Article
A novel vascular disrupting agent (NOV202) increases the anticancer efficacy of the PARP inhibitor olaparib in prostate cancer cells with BRCA1/2 mutations
Sereti, E., Evans-Axelsson, S., Rehnmark, S., Högberg, M., Bjartell, A.
Published in European urology (01.06.2021)
Published in European urology (01.06.2021)
Get full text
Journal Article
3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing
Longati, Paola, Jia, Xiaohui, Eimer, Johannes, Wagman, Annika, Witt, Michael-Robin, Rehnmark, Stefan, Verbeke, Caroline, Toftgård, Rune, Löhr, Matthias, Heuchel, Rainer L
Published in BMC cancer (27.02.2013)
Published in BMC cancer (27.02.2013)
Get full text
Journal Article
Combination of the PARP inhibitor olaparib with a novel vascular disrupting agent, NOV202, reduces tumor growth in BRCA1/2 mutated prostate cancer xenografts
Sereti, E., Evans-Axelsson, S., Hellsten, R., Rehnmark, S., Högberg, M., Bjartell, A.
Published in European urology open science (Online) (01.10.2023)
Published in European urology open science (Online) (01.10.2023)
Get full text
Journal Article
UP19 - Combination of the PARP inhibitor olaparib with a novel vascular disrupting agent, NOV202, reduces tumor growth in BRCA1/2 mutated prostate cancer xenografts
Sereti, E., Evans-Axelsson, S., Hellsten, R., Rehnmark, S., Högberg, M., Bjartell, A.
Published in European urology open science (Online) (01.10.2023)
Published in European urology open science (Online) (01.10.2023)
Get full text
Journal Article
Norepinephrine as a morphogen?: its unique interaction with brown adipose tissue
Nedergaard, J, Herron, D, Jacobsson, A, Rehnmark, S, Cannon, B
Published in The International journal of developmental biology (01.10.1995)
Get full text
Published in The International journal of developmental biology (01.10.1995)
Journal Article
39P A validation study of a self-testing capillary kit, the rhelise kit for therapeutic dose monitoring (TDM) of tamoxifen, Z-endoxifen, and 4-hydroxytamoxifen in breast cancer patients
Hedayati, E., Shabo, I., Rydberg, P., Rehnmark, S., Randahl, H., Lindqvist, A., Hall, P.F., Bergqvist, J., Wengström, Y.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
Preliminary results using a kit to measure tamoxifen and metabolites concentrations in capillary blood samples from women with breast cancer
Rehnmark, Stefan, Shabo, Ivan, Randahl, Håkan, Wengström, Yvonne, Rydberg, Per, Hedayati, Elham
Published in Scientific reports (31.01.2022)
Published in Scientific reports (31.01.2022)
Get full text
Journal Article
Transcriptional and posttranscriptional mechanisms in uncoupling protein mRNA response to cold
Rehnmark, S, Bianco, A C, Kieffer, J D, Silva, J E
Published in The American journal of physiology (01.01.1992)
Published in The American journal of physiology (01.01.1992)
Get more information
Journal Article
thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
Berkenstam, Anders, Kristensen, Jens, Mellström, Karin, Carlsson, Bo, Malm, Johan, Rehnmark, Stefan, Garg, Neeraj, Andersson, Carl Magnus, Rudling, Mats, Sjöberg, Folke, Angelin, Bo, Baxter, John D
Published in Proceedings of the National Academy of Sciences - PNAS (15.01.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (15.01.2008)
Get full text
Journal Article
Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor β subtype selective agonist KB-141
Bryzgalova, Galina, Effendic, Suad, Khan, Akhtar, Rehnmark, Stefan, Barbounis, Peter, Boulet, Jamie, Dong, Gao, Singh, Rajni, Shapses, Sue, Malm, Johan, Webb, Paul, Baxter, John D., Grover, Gary J.
Published in The Journal of steroid biochemistry and molecular biology (01.09.2008)
Published in The Journal of steroid biochemistry and molecular biology (01.09.2008)
Get full text
Journal Article
Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis
Sanyal, Sabyasachi, Båvner, Ann, Haroniti, Anna, Nilsson, Lisa-Mari, Lundåsen, Thomas, Rehnmark, Stefan, Witt, Michael Robin, Einarsson, Curt, Talianidis, Iannis, Gustafsson, Jan-åke, Treuter, Eckardt
Published in Proceedings of the National Academy of Sciences - PNAS (02.10.2007)
Published in Proceedings of the National Academy of Sciences - PNAS (02.10.2007)
Get full text
Journal Article
Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent
Rickardson, Linda, Kutvonen, Emma, Orasniemi, Satu, Högberg, Marita, Kallio, Marko J, Rehnmark, Stefan
Published in Drug design, development and therapy (01.01.2017)
Published in Drug design, development and therapy (01.01.2017)
Get full text
Journal Article